Pacific Medical Systems Limited is pleased to announce its successful participation in the 33rd Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS), held in Singapore from May 14 to 17, 2025. The landmark event, themed "Progress, Innovation and Fellowship," brought together over 1,000 leading experts, surgeons, and researchers from more than 50 countries.
As a supplier dedicated to introducing cutting-edge medical technologies, Pacific Medical Systems Limited showcased a portfolio of innovative products at the exhibition, offering attendees a forward-looking perspective on the future of cardiovascular surgery.
A Showcase of Innovation and Clinical Insight
The company's booth featured several key technologies that drew significant interest from the international audience:
- smartcanula: The Most Physiologic Blood Drainage System: Demonstrating a breakthrough in cardiac surgery, smartcanula presents the most physiological approach to blood drainage. A special highlight was a presentation by Prof. Tomas Holubec, MD, PhD, who stepped in on short notice to deliver valuable clinical insights and share his expert experience with the smartcanula system.
- Medistim MiraQ Cardiac System with Intui Platform: The highlight was the newly launched, intuitive Intui software platform. Designed to simplify intraoperative data interpretation, Intui provides surgeons with intelligent data visualization for enhanced decision-making in real-time blood flow assessment.
- Coroneo Surgical Exposure System: The Coroneo system offers unparalleled surgical access and visibility during valve surgery. Its ingenious design helps optimize surgical workflow, increasing both efficiency and patient safety.
- True Flow RDB: Antegrade Selective Cerebral Perfusion Cannula: This innovative cannula, designed for complex aortic surgery, enables precise cerebral perfusion, significantly improving patient safety and surgical outcomes during critical procedures.
Leadership Perspective on a Successful Event
Reflecting on the company's participation, Jules Flach, CEO of Pacific Medical Systems Limited, stated, "We were thrilled to be part of the ASCVTS annual meeting, a premier event in the Asia-Pacific region. This exhibition provided an invaluable platform to engage with the global cardiac surgery community and reaffirmed that our curated portfolio directly addresses evolving clinical needs. Witnessing the strong interest from leading experts in our innovative solutions was incredibly rewarding."
The meeting served as an excellent opportunity for Pacific Medical Systems Limited to strengthen existing partnerships and establish new connections with medical professionals across the Asia-Pacific region. The company remains committed to its mission of introducing world-class medical technologies to the market, contributing to improved patient outcomes and the advancement of cardiovascular surgical care.